Skip to main content

Published locations for Ibrutinib/venetoclax shows early promise in relapsed CLL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Ibrutinib/venetoclax shows early promise in relapsed CLL

User login

  • Reset your password
  • /content/ibrutinib/venetoclax-shows-early-promise-relapsed-cll
  • /hematologynews/article/169968/cll/ibrutinib/venetoclax-shows-early-promise-relapsed-cll
  • /oncologypractice/article/169968/cll/ibrutinib/venetoclax-shows-early-promise-relapsed-cll
  • /hematologynews/nhlhub/article/169968/cll/ibrutinib/venetoclax-shows-early-promise-relapsed-cll
  • /hematology-oncology/article/169968/cll/ibrutinib/venetoclax-shows-early-promise-relapsed-cll
  • /b-cell-lymphoma-icymi/article/169968/cll/ibrutinib/venetoclax-shows-early-promise-relapsed-cll